I am greatly honored to take on the responsibility of being the editor of the International Journal of Cardiodiabetes. The incidence of diabetes is increasing worldwide and although there are many therapies that effectively control blood glucose levels patients with diabetes they continue to be at an increased risk of myocardial infarction, stroke and peripheral […]
It is a great honour to have been asked to write the foreword to the inaugural edition of The International Journal of cardiodiabetes. At such a time with the COVID Pandemic still raging in many parts of the world, one might reasonably ask why at this time we need to have yet another medical journal in addition to the numerous publications that already exist? However, it is precisely the mortality, morbidity, geographical spread, economic effects, social disruption and inequalities which the Pandemic has highlighted that merit an even wider view of the importance of global healthcare. Whilst COVID is a global communicable disease, diabetes mellitus is in many senses a non-communicable equivalent with an ever burgeoning significance.
The birth of a new journal is usually a cause for singular rejoicing and anticipation. On this occasion, however, the moment is steeped in melancholy with the recent passing of Professor Avijit Lahiri, the journal’s founder. He lived life to the full. Avijit touched countless friends and colleagues with his support, kindness and mentorship. At the same time, he was a pioneer in cardiodiabetes, an excellent clinician and an outstanding academic mind. In short, he was a trailblazer.